Research Studies: Post COVID-19 Pulmonary Fibrosis

Long COVID image

Research is shedding light on the growing rate of pulmonary fibrosis (PF) being found in people suffering from long-term COVID-19. PF is a relatively unknown but deadly disease that involves irreversible scarring of lung tissue, slowly robbing a person of the ability to breathe, making it harder and harder for them to get oxygen from their lungs.

In an ominous sign that we can expect to see tens of thousands more cases of PF in Canada each year, research studies done across the world are discovering large numbers of people experiencing PF after contracting COVID-19. 

One study, Post COVID-19 pulmonary fibrosis; a meta-analysis study, found that almost 45% (44.9%) of study participants began suffering from PF after contracting COVID-19. 

Read More COVID-19 and Pulmonary Fibrosis Studies, Articles, and Resources:

Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States

Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review

Understanding post-COVID interstitial lung disease: Causes, treatment options

PFF Post COVID-19 Interstitial Lung Disease Fact Sheet